Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two aspirin doses for prevention of pre-eclampsia in high-risk pregnant women
IRCT20120918010876N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin in preeclampsia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Incidence of pre-eclampsia. Started Nov 2018; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20120918010876N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120918010876N6.